Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Friday, March 27, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for March 16, 2015 through March 20, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Health Care Research and Quality (AHRQ)

·         Office of the Assistant Secretary for Preparedness and Response (ASPR)

·         Centers for Disease Control and Prevention (CDC)

·         Health Resources and Services Administration (HRSA)

·         Office of the Assistant Secretary for Health (OASH)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

AHRQ: Small Research Grant Program

Funding Opportunity Number: PA-15-147

This Funding Opportunity Announcement (FOA) solicits applications for small research projects. This FOA will support different types of health services research projects, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, and development of new research technology. The AHRQ small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed within two years (or less) within the budget constraints of the mechanism.  Because the research strategy section of the application is limited to 6 pages, appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies. This funding opportunity was announced on March 19, 2015. The initial application deadline is June 16, 2015. For more information, please visit AHRQ's Full Funding Opportunity Announcement.

 

ASPR: National Ebola Training and Education Center

Funding Opportunity Number: EP-U3R-15-003

In recognition of the complex nature of preparing the U.S. health care system to safely assess and care for patients with suspected and confirmed cases of Ebola, ASPR and CDC seek to develop a National Ebola Training and Education Center (NETEC) that will offer state health departments, regional Ebola and special pathogen treatment centers, state- and jurisdiction-based Ebola treatment centers, and assessment hospitals expertise, training, technical assistance, peer review, monitoring, recognition, and certification, if feasible. The NETEC will build a comprehensive set of activities and deliverables for public health departments, U.S. health care providers, and facilities needed to safely and successfully identify, isolate, assess, transport, and treat patients with Ebola or persons under investigation for Ebola, and will develop and lead a national peer review and recognition program for regional Ebola and other special pathogen treatment centers and Ebola treatment centers. Throughout the five-year project period, the NETEC will modify materials developed (e.g., curricula and templates) as the Ebola outbreak evolves and the science changes. This funding opportunity was announced on March 19, 2015. The application deadline is May 20, 2015. For more information, please visit ASPR's Full Funding Opportunity Announcement.

 

 

 

CDC: Improving the Health of People with Intellectual Disabilities

Funding Opportunity Number: CDC-RFA-DD12-12010101SUPP15

The purpose of this Funding Opportunity Announcement (FOA) is to improve the health of people with intellectual disabilities (ID) by improving access to health services and promoting healthy behaviors. The program shall accomplish health improvements by (1) providing health assessments, referral to services, and education to persons with ID, (2) training health care professionals to improve their skill in caring for people with ID, (3) raising awareness of persons with ID, and (4) improving health care access. This funding opportunity was announced on March 19, 2015. The application deadline is May 20, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

HRSA: Health Careers Opportunity Program

Funding Opportunity Number: HRSA-15-042

This Funding Opportunity Announcement (FOA) solicits applications for the Health Careers Opportunity Program (HCOP). First authorized in 1972, HCOP provides grants to eligible accredited health professions schools and public and private non-profit health or educational entities.  The program’s goal is to provide individuals from disadvantaged backgrounds with an opportunity to develop the skills needed to successfully compete for, enter, and graduate from health or allied health professions schools.  HCOP focuses on three key milestones of education (1) high school completion, (2) acceptance, retention and graduation from college, and (3) acceptance, retention and completion of a health professions program.  The HCOP includes a funding preference for applicants that utilize a Comprehensive Approach – an organizational model involving partnerships between several public or nonprofit private health or educational entities to establish, enhance and expand educational programs that result in the development of a competitive applicant pool of individuals from disadvantaged backgrounds who desire to pursue health professions careers. The HCOP provides a variety of academic and social supports to individuals from disadvantaged backgrounds through formal academic and research training, programming and student enhancement or support services. The HCOP recipients provide counseling and mentoring services to assist students in successfully completing their education and training. The program also exposes students to community-based health professions experiences in underserved communities.  In addition, the HCOP provides student stipends and financial planning resources to students as well as information about health care careers and training. This funding opportunity was announced on March 16, 2015. The application deadline is May 19, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Service Area Competition for the Additional Area of Cheyenne, WY

Funding Opportunity Number: HRSA-15-147

Health centers improve the health of the Nation’s underserved communities and vulnerable populations by ensuring access to comprehensive, culturally competent, quality primary health care services. The Health Center Program grants support a variety of community-based and patient-directed public and private nonprofit organizations that serve an increasing number of the Nation’s underserved. Individually, each health center plays an important role in the goal of ensuring access to services, and combined, they have had a critical impact on the health care status of medically underserved and vulnerable populations throughout the United States and its territories.  The Health Center Program targets the Nation’s neediest populations and geographic areas by currently funding approximately 1,300 health centers that operate over 9,000 service delivery sites in every state, the District of Columbia, Puerto Rico, the Virgin Islands, and the Pacific Basin.  This Funding Opportunity Announcement (FOA) solicits applications for the Health Center Program’s Service Area Competition for Cheyenne, Wyoming. The FOA details the SAC-AA eligibility requirements, review criteria, and awarding factors for organizations seeking a grant for operational support under the Health Center Program, including Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and/or Public Housing Primary Care.  This funding opportunity was announced on March 18, 2015. The application deadline is May 19, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

OASH: National Health Education Program on Lupus

Funding Opportunity Number: MP-CPI-15-001

The purpose of the National Health Education Program on Lupus (NHEPL) is to reduce lupus-related health disparities among racial and ethnic minority populations disproportionately affected by this disease by conducting a national lupus education initiative that reaches out to the general public, health professionals and student trainees in targeted communities, schools and health care systems and practices. Grantees will be responsible for conducting at least two of the following three priority activities: (1) Conduct provider training to include physicians, nurses, pharmacists, physician assistants, nurse practitioners, and allied health professionals to engage them to improve lupus diagnosis and treatment through education, appropriate linkages to care, disease management, and enrollment in health coverage; (2) Implement a lupus program through a comprehensive community level education effort that will serve persons living with lupus and their family members. The program will include: community outreach to improve awareness and understanding of lupus and management of primary and secondary conditions; access to care and coverage to increase the number of persons linked to health care services and enrolled in health coverage; and communication strategies such as electronic media and patient/provider software application development to improve disease management and outcomes and patient/provider communication. (3) Develop and maintain patient and family care networks to identify strategies that address the emotional and social support needs of individuals diagnosed with lupus and their families and improve care coordination across the health care delivery system. This funding opportunity was announced on March 16, 2015. The application deadline is May 18, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

OASH: National Workforce Diversity Pipeline Program

Funding Opportunity Number: MP-CPI-15-002

The National Workforce Diversity Pipeline Program (NWDP) seeks to address health disparities among racial and ethnic minorities by supporting networks of institutions focused on, and with demonstrated commitment and capacity to establish pipeline programs to increase minority and disadvantaged students awareness of and pursuit in the areas of health care and behavioral health and increase the availability of STEM education programs. This funding opportunity was announced on March 17, 2015. The application deadline is May 18, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

OASH: Partnerships to Increase Coverage in Communities II Initiative

Funding Opportunity Number: MP-CPI-15-003

The Affordable Care Act established a new Health Insurance Marketplace (Marketplace), that has enabled millions of individuals to obtain and purchase affordable health coverage. The Affordable Care Act has created a streamlined system for helping people connect with the health coverage options that best meet their needs while maximizing electronic data exchanges and other technology to reduce the application burden. Some of the features of the Marketplace include (1) the option for eligible individuals to apply for affordable health coverage programs (Medicaid, the Children’s Health Insurance Program (CHIP), premium tax credits and cost-sharing reductions), and (2) enabling individuals and families to apply for coverage using a single streamlined application. The need for outreach efforts continues in order to ensure that the public, including minority populations, understand these health insurance options and receive the assistance they need to obtain coverage through the Marketplace as smoothly as possible. Since its enactment, the Affordable Care Act has reduced the number of uninsured and the overall costs of health care. However, racial and ethnic minority remain at disproportionate risk of still being uninsured. For the purpose of this announcement, minority populations include American Indian, Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian and other Pacific Islanders, consistent with the Standards for Classification of Federal Data on Race and Ethnicity. The actions under the PICC II Initiative will provide funding to successful applicants to educate various populations, including racial and ethnic minority populations and those that are economically and environmentally disadvantaged (see Appendix A), and to assist them with completion of the Marketplace’s streamlined health insurance application to determine their eligibility to purchase a health insurance plan offered through the Marketplace or for Medicaid and the Children’s Health Insurance Program (CHIP). Successful applicants will have established relationships with coalitions/partners and have a demonstrated track record of working with racial and ethnic minority populations including those that are economically and environmentally disadvantaged to develop and implement a strategy to educate eligible target population(s) about the Affordable Care Act, the Marketplace and the application process. Applicants in states in which the Federally Facilitated Marketplace (FFM) does not operate may also apply for these funds. However, they must work with the State-based Marketplace (SBM) in their state to receive training and educational materials. Successful applicants in states in which the FFM operates must use materials developed by the Centers for Medicare & Medicaid Services (CMS) on the Affordable Care Act, the Marketplace, and the Marketplace application process to ensure that the information given to the targeted populations is correct. Overall outreach efforts and assistance offered in completing the application must be culturally and linguistically appropriate. This funding opportunity was announced on March 19, 2015. The application deadline is May 22, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

USAMRAA: ALS Therapeutic Idea Award

Funding Opportunity Number: W81XWH-15-ALSRP-TIA

The Therapeutic Idea Award is designed to promote new ideas aimed at drug, treatment, and target discovery that are still in the early stages of development. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advance a novel treatment modality. Projects that focus primarily on investigating the pathophysiology of ALS are outside the scope of this mechanism. In addition to hypothesis-based ideas aimed at drug or treatment discovery, the FY15 Therapeutic Idea Award will support the development, validation, and application of high-throughput screens to define targets with therapeutic potential or to identify lead agent candidates for ALS treatment, as well as the development, modification, and/or validation of preclinical model systems in order to assess lead compounds and potential therapeutics by pharmacological and/or pharmacokinetic testing. Such models would also serve as improved tools for the ALS research community. Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data, but on the innovative idea and the potential impact it will provide. This funding opportunity was announced on March 18, 2015. The application deadline is August 20, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: ALS Therapeutic Development Award

Funding Opportunity Number: W81XWH-15-ALSRP-TDA

The Therapeutic Development Award supports the preclinical development of therapeutic leads for ALS. The proposed studies are expected to be empirical in nature and product-driven. The maximum period of performance is 2 years. Applications must clearly identify a lead molecule, or limited group of lead molecules, possessing demonstrated biological activity on a pathway relevant to ALS disease onset and/or progression. The FY15 Therapeutic Development Award supports a wide range of post-discovery development activities ranging from post-discovery validation right up to IND submission. Supported activities must begin with lead compounds in hand and can include (1) secondary validation of leads obtained from screening or by other means to demonstrate target selectivity and mechanism of action, (2) optimization of potency and pharmacological properties and development of structure-activity maps via synthesis and testing of derivatives and sister compounds, (3) studies of formulation and stability, and/or (4) development of GMP production methods, (5) collection of data needed for Food and Drug Administration (FDA) Investigational New Drug (IND) applications to include compound characterization, absorption, distribution, metabolism, excretion (ADME) studies, and dose/response and toxicology studies. Validation of existing biomarkers and development of them as markers for mechanism-specific drug activity and/or clinical progression, in parallel with therapeutic lead validation and development, is also of interest. This funding opportunity was announced on March 18, 2015. The application deadline is August 20, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

 

NIH Funding Opportunity Announcements:

 

NIH: Comparative Physiological Studies of Aging

Funding Opportunity Number: RFA-AG-16-003

The purpose of this Funding Opportunity Announcement (FOA) is to support small research projects that involve comparative studies of biological pathways that may explain differences in lifespan and health span phenotypes in vertebrate species and that can be carried out in a short period of time with limited resources. Studies involving comparative approaches, both across a broad range of species and across closely related species or strains with different lifespans, could identify components in the pathways that are conserved in function and therefore, potential targets for intervention. At the molecular level, major pathways affecting longevity have been identified, including the IIS/IGF, sirtuins and mTOR pathways. The fact that these pathways are highly conserved from invertebrates all the way to humans makes them a potentially informative target for comparative biology approaches, as well as druggable targets for potential intervention into humans. The overall objective of this FOA is to identify both molecular and physiological targets that are potentially amenable to intervention strategies to promote healthy aging.  The information from comparative studies will make a major contribution toward understanding age-associated changes. Extending health span by delaying and slowing-down age-related changes would benefit individuals and reduce healthcare costs associated with the older population. This funding opportunity was announced on March 17, 2015. A letter of intent is due by May 2, 2015. The application deadline is June 2, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: International Research Collaboration on Drug Abuse and Addiction Research

Funding Opportunity Numbers: PA-15-141, PA-15-142, and PA-15-143

These Funding Opportunity Announcements (FOAs) encourage collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of the National Institute of Drug Abuse (NIDA) and where feasible should address NIDA’s international scientific priority areas. While the priorities will change from year to year, in FY15 priority areas include (1) linkages between HIV/AIDS and drug abuse, (2) prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders), (3) the neuroscience of marijuana and cannabinoids, and (4) the effect of changes in laws and policies on marijuana and its impact. The NIH R03 activity code supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. FOA PA-15-141 supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. FOA PA-15-143 is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. These funding opportunities were announced on March 17, 2015. The initial application deadline for PA-15-142 is June 5, 2015. The initial application deadline for both opportunities PA-15-141 and PA-15-143 is June 16, 2015.  For more information, please visit NIH's Full Funding Opportunity Announcements for PA-15-141, PA-15-142, and PA-15-143.

 

NIH: Molecular Imaging of the Lung - Phase 2

Funding Opportunity Number: RFA-HL-16-001

This Funding Opportunity Announcement (FOA) invites applications to develop novel in vivo imaging technologies using molecular probes that target pathways or cells involved in the pathobiology of pulmonary diseases. The long-term goal of this program is to develop novel molecular imaging entities and approaches that facilitate early detection and diagnosis of lung disease, enable noninvasive monitoring of lung disease progression and prognosis, and accelerate progress of cell-specific drug delivery and therapies. Phase 1 of this initiative (FOA number RFA-HL-12-036) supported projects to develop and validate innovative novel imaging agents and approaches that included target selection, probe development and production, and initial characterization of the probe. Phase 2 of this initiative will support studies that advance translation of identified probes and associated imaging approaches from animal models into applicability for human lung diseases. Phase 2 studies must include work performed in vivo using appropriate animal models of lung disease and studies using human tissues and/or cells. Applications proposing Investigational New Drug (IND)-enabling studies of novel probes and imaging approaches are encouraged. Applicants are not required to have been funded in Phase 1 in order to submit applications for Phase 2. This funding opportunity was announced on March 17, 2015. A letter of intent is due by May 15, 2015. The application deadline is June 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: The Role of Exosomes in HIV Neuropathogenesis

Funding Opportunity Numbers: RFA-MH-16-100 and RFA-MH-16-110

These Funding Opportunity Announcements (FOAs) invite small research grant applications focused on defining the central role of exosomes in the neuropathogenesis of Human Immunodeficiency Virus (HIV)-1 Associated Neurocognitive Disorders (HAND) and determining the potential use of exosomes as biomarkers for HAND or as delivery vehicles for central nervous system (CNS) targeted therapeutics. HIV-Associated Neurocognitive Disorders remain prevalent despite the widespread use of potent anti-retroviral drug regimens. Low levels of viral replication and chronic inflammation continue to persist in the CNS in well treated patients. There remain considerable gaps in our understanding of the pathophysiologic mechanisms driving HIV-1 associated neurocognitive decline in the setting of low levels of viral replication. The release of inflammatory mediators by macrophages/microglial cells and astrocytes contributes to the pathogenesis of HAND. The mechanisms by which HIV-related inflammation spreads within the CNS compartment are an area that requires further study. In particular there is a great need to define the communication pathways between macrophages, astrocytes and neuronal cells within the CNS in the setting of HIV-infection. These funding opportunities were announced on March 20, 2015. A letter of intent for each opportunity is due by August 2, 2015. The initial application deadline for both opportunities is June 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements for RFA-MH-16-100 and RFA-MH-16-110.

 

NIH: Supplements to Support Interoperability of NIH Funded Biomedical Data Repositories

Funding Opportunity Number: PA-15-144

This Funding Opportunity Announcement (FOA) solicits administrative supplement requests to support projects that will establish or improve interoperability among NIH-funded biomedical data repositories. Improved interoperability is expected to lead to increased efficiency of repositories’ operations and cost reductions, which are significant factors of the NIH’s long-term sustainability plans for the biomedical data repositories. Biomedical research is an increasingly data intensive enterprise due in part to the rapid advance of many life science technologies. This data enterprise has created a multitude of repositories, which are growing in both scale and complexity for the preservation and distribution of data across the scientific community. With growing datasets and flat research budgets around the world, a major challenge for the NIH is to develop effective means of sustaining biomedical data repositories and the knowledge accumulated in them beyond 5-10 year funding cycles. Each supplement request should be associated to a collaborative project consisting of a biomedical data repository supported by an active NIH-funded parent grant, and one or more collaborating sites that together implement the interoperability goals of this FOA. The collaborating sites may be other biomedical data repositories, or may provide computational tools and data standards, or perform other activities that facilitate interoperability among data repositories. This funding opportunity was announced on March 18, 2015. The application deadline is April 20, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Administrative Supplements for Ebola Biosafety and Infectious Disease Response Training

Funding Opportunity Number: PA-15-148

The purpose of this Funding Opportunity Announcement (FOA) is to provide supplemental support to conduct worker-based training to prevent and reduce exposure of hospital employees, emergency first responders, and other workers who are at risk of exposure to Ebola through their work duties. The National Institute of Environmental Health Sciences (NIEHS) Superfund Worker Training Program (WTP) will work collaboratively to develop and target safety and health training for those workers supporting the national Ebola response. Using our hazmat trainers understanding of worker safety and health protection issues, knowledge of personal protective equipment (PPE) usage, and experience in training disaster workers, WTP will coordinate with CDC, the Occupational Safety and Health Administration, and the National Institute for Occupational Safety and Health to provide awardees with material to develop an evidence-based curriculum that addresses the science of Ebola (clinical symptoms, mode of transmission, persistence in the environment, and treatment); infection control and worker protection (isolation/quarantine and PPE); working in the contaminated environment (sampling and decontamination); and behavioral health resiliency. This funding opportunity was announced on March 19, 2015. The application deadline is April 20, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence

Funding Opportunity Number: PAR-15-146

This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence. The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy, through Investigational New Drug (IND)-enabling studies required for advanced development. The CounterACT Centers will contain at least three research projects supported by administrative and scientific cores, and a research education core. Each research project must include milestones that create discrete go or no-go decision points in a progressive translational study plan. This funding opportunity was announced on March 19, 2015. The initial application deadline is September 15, 2015. A letter of intent is due 30 days prior to the corresponding application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Research Education Mentoring Programs for HIV/AIDS Researchers

Funding Opportunity Number: PAR-15-145

The NIH Research Education Program supports research education activities in the mission areas of the NIH. The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and advance the priorities outlined in the Office of AIDS Research (OAR) Annual Strategic Plan and the research program priorities of the NIMH Division of AIDS Research (DAR). To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Mentoring Activities and Research Experiences, that either capitalize on existing networks of collaborating investigators or develop institute-based research education programs. Mentoring activities are expected to be primary and the cornerstone of proposed programs though all programs must also provide research experiences. Research Education Programs are expected to enhance the professional development of the participants and foster a career trajectory towards independent research in the mental health of HIV/AIDS. This funding opportunity was announced on March 19, 2015. The initial application deadline is September 7, 2015. A letter of intent is due 30 days prior to the corresponding application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal